home
portfolio
approach
team
careers
news
contact
investor portal
home
portfolio
approach
team
careers
news
contact
investor portal
Nextech Invest
Silverback Therapeutics™ Initiates Phase 1 Clinical Study of SBT6050
Silverback Therapeutics™ Initiates Phase 1 Clinical Study of SBT6050
Post navigation
Previous Post
Previous
Kinnate Biopharma Closes $98 Million Series C Financing
Next Post
Next
https://arrakistx.com/news/press-releases/arrakis-therapeutics-publishes-advanced-research-method-to-systematically-identify-rna-targeted-small-molecules/